The Role of Psychedelics in Treating Mental Health Disorders: A Mini-Review

Abstract

Psychedelic substances are gaining attention as potential alternative or adjunct therapies for mental health disorders such as major depressive disorder and post-traumatic stress disorder. Traditional approaches do not work all the time, and they can cause serious side effects; thus, we need to look for other treatment options. In this paper, we analyze the past and present use of psilocybin, MDMA, ketamine, and other psychedelics in medicine, science, and research. It gives historical background for psychedelic studies early on to the research in the mid-20th century and speaks about the present-day research into their neurobiological effects and how they echo past findings. Also, the essay talks about the ethical and legal problems with the use of psychedelics. Moreover, it says why the past is important in the modern development of science. The conversation also considers how early exploration of psychedelics mirrors present-day surveying on their psychotomimetic and consciousness-altering properties. This work aims to address both scientific and ethical concerns to depict the therapeutic potential of psychedelics and the implications of their prohibition. In conclusion, this essay proposes directions for future research on the legal and ethical issues involving such therapies.